PPARD and neoplasm: The findings discussed above are consistent with a model where PPARβ/δis required to modulate the angiogenic response to growth factors during thefinal stages of tumor angiogenesis, which is characterized by an inhibition ofEC proliferation and the acquisition of a fully differentiated phenotype [36].